Cellect Biotechnology Gets European Patent (APOP) – Investopedia

Posted: Published on April 5th, 2017

This post was added by Dr P. Richardson


Nasdaq
Cellect Biotechnology Gets European Patent (APOP)
Investopedia
secured a European patent covering a method of treatment from the European Patent Office. The patent covers cell-based therapeutics of Cellect's technology and method that have the potential to treat diseases like diabetes, graft-versus-host disease, ...
BRIEF-Cellect Biotechnology receives formal notice of intention to grant for a patent from European patent officeReuters
UPDATE: Cellect Biotechnology (APOP) Granted European Patents ...StreetInsider.com
Cellect Biotechnology Ltd. (NASDAQ:APOP) reported an European patent grantBenchmark Monitor

all 9 news articles »

Read the original:
Cellect Biotechnology Gets European Patent (APOP) - Investopedia

Related Posts
This entry was posted in Biotechnology. Bookmark the permalink.

Comments are closed.